Share on StockTwits

iShares NASDAQ Biotechnology Index (ETF) (NYSE:IBB) was downgraded by Barclays from a “positive” rating to a “neutral” rating in a research note issued on Wednesday.

iShares NASDAQ Biotechnology Index (NYSE:IBB) opened at 263.12 on Wednesday. The stock has a 50-day moving average of $0. and a 200-day moving average of $0..

iShares Nasdaq Biotechnology ETF (NYSE:IBB), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF).

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.